8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Jun 16, 2023 · 3y ago · Accession 0000950170-23-028611
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Intellia Therapeutics, Inc.
- Ticker
- NTLA
- CIK
- 1652130
- Form type
- 8-K
- Filing date
- Jun 16, 2023
- Report date
- Jun 14, 2023
- Document
- ntla-20230614.htm
- Size
- 268 KB